Morningstar Investor users sign in here.
TOPIC

CSL News & Analysis

CSL trial fails to meet hoped for results
Stocks
CSL trial fails to meet hoped for results
How our analyst views the shares after the clinical trial set-back.
Shane Ponraj | 12 February 2024
The art of buying stocks at 52-week lows
Stocks
The art of buying stocks at 52-week lows
Stock markets are highly efficient in the long run yet share prices can fluctuate wildly near term. The art of investing is buying quality stocks...
James Gruber | 23 November 2023
The legendary growth manager's warning for investors
Markets
The legendary growth manager's warning for investors
Thomas Rowe Price Jnr shocked Wall Street in the mid-60s by presciently selling growth stocks and buying real assets. His warnings to growth...
James Gruber | 14 September 2023
Why this bull market can't last
Markets
Why this bull market can't last
Schroders' Australian equity team say investors piling into tech stocks again are ignoring a turning point in markets.
James Gruber | 06 September 2023
What did Morningstar subscribers buy and sell during earnings season?
Stocks
What did Morningstar subscribers buy and sell during earnings season?
And what do our analysts think of the stocks?
Shani Jayamanne | 04 September 2023
My latest investment checks all my boxes
Personal Finance
My latest investment checks all my boxes
Aligning a share to your investment strategy is the key to investing successfully. This ASX share with a moat is finally trading at an attractive...
Mark LaMonica, CFA | 28 August 2023
CSL's outlook improving
Stocks
CSL's outlook improving
CSL’s share price reacted positively to results but our analyst is looking at the long-term prospects.
Morningstar | 16 August 2023
Share plunge presents undervalued opportunity for well-known ASX blue chip
Stocks
Share plunge presents undervalued opportunity for well-known ASX blue chip
Shares in this well-known ASX20 stock have tumbled in recent weeks, but is the market selloff overdone?  
Joshua Peach | 11 July 2023
3 top picks from Morningstar Investor subscribers
Stocks
3 top picks from Morningstar Investor subscribers
What do our analysts think about Morningstar Investor subscriber's top trades in June so far?
Shani Jayamanne | 26 June 2023
Does the CSL selloff present a rare opportunity for investors?
Stocks
Does the CSL selloff present a rare opportunity for investors?
Shares in the ASX giant were sold off on Wednesday as currency headwinds weigh on CSL's near-term margin recovery, but we believe the long-term...
Shane Ponraj | 14 June 2023